HIF1A and cancer: Vila et al.28 introduced UBE2O deletion into a series of transgenic mouse models of spontaneous cancer and revealed that UBE2O could facilitate tumour progression and metastasis in a UBE2O/AMPKα2/HIF-1a-dependent manner.